miR-126 Functions as a Tumor Suppressor by Targeting SRPK1 in Human Gastric Cancer
Authors:
Open Access
- 17 October 2018
- journal article
- retracted article
- Published by Tech Science Press in Oncology Research
- Vol. 26 (9) , 1345-1353
Abstract
The expression of miR-126 and serine‐arginine protein kinase 1 (SRPK1) are linked to tumor development; nevertheless, its role in the tumor growth and invasion of gastric cancer (GC) and the underlying mechanism have not been clarified. Here the expression and role of miR-126 and SRPK1 were investigated in GC tissues and cells by in vitro assay, and then targets of miR-126 were identified by dual-luciferase reporter assay. In this study, miR-126 expression was downregulated and associated with lymph node metastasis and poor prognosis as well as SRPK1 expression. In vitro assay revealed that miR-126 obviously inhibited the proliferative and invasive capabilities of GC cells. The dual-luciferase reporter assay showed that miR-126 targets the 3′-UTR of SRPK1 and downregulates its expression. SRPK1 overexpression promoted cell migration and invasion. In conclusion, the reduced expression of miR-126 is suggestive of the risk of GC recurrence and metastasis, and miR-126 functions as a tumor suppressor by targeting SRPK1 expression in the development of GC.Keywords
This publication has 25 references indexed in Scilit:
- MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZCell Death & Disease, 2015
- Early Disturbed Placental Ischemia and Hypoxia Creates Immune Alteration and Vascular Disorder Causing PreeclampsiaArchives of Medical Research, 2014
- SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancerCell Death & Differentiation, 2014
- MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expressionBioscience Reports, 2014
- MicroRNA-206 suppresses gastric cancer cell growth and metastasisCell & Bioscience, 2014
- MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4Journal of Cancer Research and Clinical Oncology, 2012
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialThe Lancet, 2012
- MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancerJournal of Cellular and Molecular Medicine, 2010
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006